Article
Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy.
DNA repair - 1 Jan 2021
Vierstraete Jeroen, Fieuws Charlotte, Willaert Andy, Vral Anne, Claes Kathleen Bertha Michaël
Abstract excerpt
Double strand break (DSB) repair through Homologous Recombination (HR) is essential in maintaining genomic stability of the cell. Mutations in the HR pathway confer an increased risk for breast, ovarian, pancreatic and prostate cancer. PARP inhibitors (PARPi) are compounds that specifically target tumours deficient in HR. Novel PARPi are constantly being developed, but research is still heavily focussed on in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
